#Therapeutic Apheresis Market Market Growth
Text
Therapeutic Apheresis Market Analysis By Emerging Growth Factors And Revenue Forecast To 2032
The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2577.9 Mn in 2022 and is expected to reach US$ 5313 Mn by 2032.
The demand for therapeutic apheresis is surging owing to growing incidences of chronic diseases and an increasing number of trauma and injury cases. Therapeutic apheresis is a procedure of the removal of a blood component from a patient using the apheresis technology. Therapeutic apheresis is used for the purpose of removing defective cells. Therapeutic apheresis is also used for the treatment of conditions in which a component or a pathogenic substance in the blood causes morbidity.
Basically there are three types of therapeutic apheresis procedure used, namely therapeutic plasma exchange (TPE), red blood cell exchange (RBCX) and cellular depletions. TPE is the removal of large volume of patient plasma and replacement of the plasma with appropriate fluids. TPE is commonly used for the treatment of autoimmune diseases or immune mediated diseases or disorders.
Read Complete Analysis Report With Table Of Content: https://www.futuremarketinsights.com/reports/therapeutic-apheresis-market
TPE removes monoclonal antibiotics, paraproteins, autoimmune antibodies and antigen-antibody complexes. Therapeutic apheresis selectively removes the substantial proportion of one or more components causing diseases.
Therapeutic Apheresis Market: Drivers and Restraints
Increasing use of therapeutic apheresis in the treatment of cancer will increase the growth of the global therapeutic apheresis market. In addition, increasing prevalence of chronic disorders and geriatric population will also increase the growth of the global therapeutic apheresis market. Rise in healthcare expenditure will further boost the global therapeutic apheresis market. However, the lack of awareness and high cost of the procedures hampers the growth of the global therapeutic apheresis market.
Therapeutic Apheresis Market: Overview
Therapeutic apheresis is a term which is used for the treatments and removal of chemicals, harmful proteins, or cells in the blood that contribute to disease. Therapeutic apheresis includes plasma exchange and cytapheresis. Therapeutic apheresis is helpful for those patients who are facing a variety of medical conditions.
Therapeutic apheresis is mainly used to treat patients suffering with blood disorders, kidney disorders, neurologic disorders and metabolic disorders. Based on technology, the global therapeutic apheresis market is segmented into centrifugation and membrane filtration. Based on end user, the market is segmented into hospitals, blood banks and specialty clinics.
Therapeutic Apheresis Market: Regional Outlook
Geographically, global therapeutic apheresis market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominated the global therapeutic apheresis market owing to its well-established healthcare infrastructure and high demand for plasma for production of plasma derived medicines.
Asia Pacific, with its considerably established therapeutic apheresis market in countries such as Japan and emerging economies such as India and China, is projected to witness exponential growth during the forecast period.
In addition, increasing rise in the prevalence of chronic diseases, high geriatric population, and increasing healthcare expenditure in this region will play the key role in the demand for therapeutic apheresis procedures in the next few years and this will surely increase the growth of the global therapeutic apheresis market.
Therapeutic Apheresis Market Key Players
Some of the players identified in global therapeutic apheresis market include Miltenyi Biotec, Fresenius Kabi USA, Terumo Bct, Inc., Baxter Healthcare Corporation, Medica S.p.A., and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
Regional analysis includes
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
#Therapeutic Apheresis Market Market#Therapeutic Apheresis Market Market Size#Therapeutic Apheresis Market Market Growth
0 notes
Text
Leukapheresis Market Size, Share, Trends and Revenue Forecast 2028
Leukapheresis Market in terms of revenue was estimated to be worth $70 million in 2023 and is poised to reach $100 million by 2028, growing at a CAGR of 8.3 % from 2023 to 2028 according to a new report by MarketsandMarkets™. The global leukopaks market is anticipated to reach USD 1020 million by 2028 from USD 200 million in 2023, at a CAGR of 38.1%. The leukopaks market is driven by the increasing demand for leukopaks in research applications, such as the development of new cancer treatments. The demand for leukopaks is growing due to the increasing number of research studies being conducted on cancer. The development of new cancer treatments is also driving the demand for leukopaks. Other factors that are contributing to the growth of the leukopaks market include the increasing incidence and prevalence of cancer, the growing popularity of personalized medicine, advances in medical technology, and growing awareness about leukopaks and their benefits in developing nations.
Download an Illustrative overview:
Browse in-depth TOC on "Leukapheresis Market"
230 - Tables
80 - Figures
295 – Pages
The disposables segment accounted for the larger share of the leukapheresis products market.
By type, the leukapheresis products market can be segmented into devices and disposables. The disposables segment occupied a larger share of the leukapheresis products market in 2022. The disposables used in leukapheresis procedures are products used to access blood vessels and store blood components, replacement fluids, and anticoagulants to prevent blood from clotting in the process. Disposables are used for both automated blood collection and therapeutic leukapheresis. They include apheresis catheters, needle sets, centrifuge bowls, tubing sets/pipeline systems, collection bags, and various solutions such as saline, anticoagulants, media, columns, filters, and cell separation kits.
The mobilized leukopaks segment dominated the leukopaks market based on type.
By type, the leukopaks market is categorized into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. The mobilized leukopaks segment dominated the leukopaks market in 2022. Mobilized leukopaks are mainly used in preclinical and clinical research in a variety of fields, including cancer immunotherapy, cell therapy, and regenerative medicine. Charles River Laboratories (US), Discovery Life Sciences (US), StemExpress (US), BioIVT (US), and Caltag Medsystems (UK) are some of the major players offering mobilized leukopaks for research and clinical applications.
North American region dominated the Leukapheresis market with the largest market share.
The Leukapheresis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America reported the largest share of the Leukapheresis market in 2022. The incidence and prevalence of leukemia are increasing in North America, due to factors such as environmental pollution, exposure to radiation, and unhealthy lifestyle habits. This is driving the demand for leukapheresis products, which are used to treat leukemia.
Request Sample Pages:
Leukapheresis Market Dynamics:
Drivers:
1. Increased demand for leukopaks in clinical research
Restraints:
1. Complications associated with therapeutic leukapheresis
Opportunities:
1. Gaps in current leukapheresis technologies
Challenges:
1. Blood transfusion safety in developing countries
Key Market Players:
Key players in the leukapheresis products market include Asahi Kasei Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Macopharma SA (France), and Miltenyi Biotec (Germany). Some prominent players in the leukopaks market are Discovery Life Sciences (US), StemExpress, LLC (US), Charles River Laboratories International, Inc. (US), Caltag Medsystems Limited (UK), Lonza Group AG (Switzerland), and ZenBio (US). These companies adopted strategies such as product launches, business expansions, agreements, partnerships, and acquisitions to strengthen their presence in the Leukapheresis market.
Get 10% Free Customization on this Report:
Leukapheresis Market Advantages:
· Targeted Cell Collection: Leukapheresis enables precise isolation and collection of specific white blood cell populations, ensuring higher purity and potency of cells for various therapeutic applications.
· Personalized Medicine: The technique contributes to personalized medicine by tailoring treatments to individual patients, leveraging their unique genetic profiles for more effective and customized therapies.
· Efficiency and Automation: Ongoing innovation and automation within the leukapheresis industry streamline procedures, reducing treatment time, patient discomfort, and optimizing cell yield for improved outcomes.
· Consistency and Reliability: Automation ensures consistent cell collection, enhancing reproducibility and reliability in research and clinical applications.
· Therapeutic Breakthroughs: Leukapheresis has facilitated advancements in treating diseases like cancer and autoimmune disorders through the development of novel therapies like CAR-T cell therapy.
· Research Advancements: The technique supports medical research by providing researchers with purified cell populations for studying disease mechanisms, drug development, and therapy optimization.
· Reduced Side Effects: Targeted cell collection minimizes unwanted side effects by focusing only on the specific cell populations needed for treatment.
· Minimized Patient Risk: Leukapheresis reduces the need for invasive procedures, lowering patient risk while obtaining essential cells for treatment.
· Expanded Treatment Options: The technique expands the range of treatment options available to patients, especially for those with limited alternatives or complex medical conditions.
· Clinical Versatility: Leukapheresis finds applications across various medical fields, from cancer and immunology to regenerative medicine, showcasing its versatility in addressing different health challenges.
· Pioneering Cellular Therapies: The advancements in leukapheresis techniques have been instrumental in driving the development and success of cutting-edge cellular therapies.
· Improved Patient Outcomes: By enhancing the quality and effectiveness of isolated cell populations, leukapheresis contributes to improved patient outcomes and quality of life.
· Cost-Effectiveness: In the long term, leukapheresis can offer cost-effective solutions by providing more targeted treatments, potentially reducing the need for extensive and costly interventions.
· Medical Progress: The leukapheresis market represents a significant stride toward the future of medicine, fostering innovation and progress in healthcare through its specialized cell collection capabilities.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/leukapheresis-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/leukapheresis.as
#Leukapheresis Market#Leukopaks Market Size#Leukapheresis Devices Market Share#Centrifugal Devices Industry Growth
0 notes
Text
Apheresis Equipment
The global Apheresis equipment market is poised to exceed US$ 1,770 million in 2019, showcasing a remarkable CAGR of 9.8% and offering lucrative opportunities for industry participants. Apheresis equipment play a crucial role in collecting and separating blood components for therapeutic procedures and donations. These devices are integral in treating various conditions such as Preeclampsia, Goodpasture syndrome, eclampsia, leukostasis polymyositis or dermatomyositis, and rheumatoid arthritis.
To read more about the topic please visit site: https://bekryl.com/industry-trends/apheresis-equipment-market-share-analysis
The market is propelled by a rising demand for blood supply, an increase in the geriatric population, and a growing prevalence of blood disorders. Chronic diseases, particularly cardiovascular diseases, are on the rise at an alarming rate, with cardiovascular disease increasing annually by an estimated 3.8%.
Global Apheresis Equipment Market Size: By Product
In terms of products, the industry's revenue is dissected into devices and accessory kits. Apheresis equipment contributes to 41% of global sales, with subcategories including automated, semi-automated, and others. Automated equipment, driven by changes in the healthcare business model, eliminates operator involvement through sensor-based processes.
Global Apheresis Equipment Market Size: By Procedure
Plasmapheresis stands out as the most commonly used procedure, claiming a 53% share in 2018. This dialysis-like procedure filters blood to eliminate toxic antibodies, and the frequency of plasmapheresis treatments varies from patient to patient.
Global Apheresis Equipment Market, By Region
Globally, North America dominates the apheresis equipment market, contributing to 38.3% of total sales in 2018. The region boasts a robust healthcare infrastructure and higher healthcare spending, creating a favorable ecosystem. Meanwhile, Asia Pacific is poised for rapid growth, led by China and Japan. The region's improving healthcare facilities and the surge in chronic cases are driving overall sales.
Global Apheresis Equipment Market Size and Forecast: Competition Landscape
The industry exhibits high consolidation, with Fresenius, Terumo, and Haemonetics collectively accounting for over 83% of global sales. Key players highlighted in the report include:
Fresenius Kabi
Terumo Corporation
Haemonetics Corporation
Asahi Kasei Medical Co. Ltd.
Braun Melsungen AG
Kaneka Corporation
This market is characterized by its potential for substantial growth, driven by technological advancements and an increasing focus on addressing prevalent health issues.
0 notes
Text
DelveInsight's Comprehensive Insights into Parkinson's Disease Market Dynamics
DelveInsight's Parkinson's Disease Market Insights report offers a thorough understanding of current treatment practices, emerging drugs, market share of individual therapies, and the current and forecasted market size from 2019 to 2032. The report provides segmentation for 7MM (the United States, the EU-4 - Italy, Spain, France, and Germany, the United Kingdom, and Japan).
Click here to know Parkinson’s Disease Market
Key Takeaways from the Parkinson's Disease Market Report:
Parkinson's Disease Market Size and Prevalence:
The Parkinson's disease market size in the 7MM was approximately USD 3.2 billion in 2022.
Estimated total diagnosed prevalent Parkinson's disease cases in the 7MM were around 2.5 million in 2022.
Leading Parkinson's Disease Companies and Drug Development:
Key industry leaders, including Cerevel Therapeutics, Pfizer, Pharma Two B, AbbVie, Biogen, Denali Therapeutics, and others, are actively developing novel Parkinson's disease drugs.
Promising therapies in the pipeline include Tavapadon, P2B001, ABBV-951 (foscarbidopa/foslevodopa), BIIB122/DNL151, and more.
Parkinson's Disease Epidemiological Segmentation:
DelveInsight estimates approximately 2.5 million diagnosed prevalent cases of Parkinson's disease in the 7MM in 2022.
Parkinson's disease is identified as a male-dominant disease, with 54% of cases in males and 46% in females in the 7MM.
Click here to know Parkinson’s Disease Market
Parkinson's Disease Overview:
Parkinson's disease is a degenerative ailment characterized by the loss of nerve cells in the substantia nigra, a brain region governing movement. The exact cause remains unknown, but a combination of genetic and environmental factors is suspected. Motor symptoms such as bradykinesia, stiffness, rest tremor, and postural instability are common, accompanied by non-motor symptoms impacting a patient's quality of life.
Parkinson's Disease Epidemiological Segmentation:
The Parkinson's disease market report offers epidemiological analysis for the study period 2019–2032, segmented into diagnosed prevalent population, gender-specific diagnosed prevalent population, age-specific diagnosed prevalent population, and stage-specific diagnosed prevalent population.
Parkinson's Disease Treatment Landscape:
The Parkinson's Disease treatment landscape involves various drugs, with Levodopa being the gold standard for managing motor problems. Medications such as levodopa, dopamine agonists, MAO B inhibitors, catechol o-methyltransferase inhibitors, and others aim to reduce motor symptoms. INBRIJA (levodopa) is a notable inhalation therapy supplementing daily carbidopa-levodopa medications to alleviate "off-episodes" and motor symptoms.
Pipeline Parkinson's Disease Therapies and Key Companies:
The pipeline includes potential therapies like Tavapadon, P2B001, ABBV-951, BIIB122/DNL151, and others developed by leading companies such as Cerevel Therapeutics, Pfizer, AbbVie, Biogen, and more.
Parkinson's Disease Market Dynamics:
The Parkinson's disease market is anticipated to evolve, driven by research and development efforts, emerging therapies, and improvements in diagnosis rates. However, challenges such as the absence of a cure, symptomatic treatments, side effects, and undetected cases may impede growth. The robust pipeline and advancements in disease-modifying treatments offer optimism for the future.
In conclusion, DelveInsight's Parkinson's Disease Market Insights report provides a comprehensive understanding of the current landscape, promising therapies, and challenges, guiding stakeholders in making informed decisions.
Click here to know Parkinson’s Disease Market
Trending Reports:
Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
Cervical Cancer Market Size: https://www.delveinsight.com/report-store/cervical-cancer-market
Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
Alopecia Market: https://www.delveinsight.com/report-store/alopecia-market
Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
Cerebral Aneurysm Market: https://www.delveinsight.com/report-store/intracranial-aneurysms-market-insight
Scleroderma Market: https://www.delveinsight.com/report-store/scleroderma-market
Cervical Intraepithelial Neoplasia Market: https://www.delveinsight.com/report-store/cervical-cancer-market
Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
Osteoarthritis Market: https://www.delveinsight.com/report-store/osteoarthritis-market
Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
Eczema Market: https://www.delveinsight.com/report-store/eczema-market
Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
Bone Grafts And Substitutes Market: https://www.delveinsight.com/report-store/bone-grafts-and-substitutes-market
Neuroblastoma Market: https://www.delveinsight.com/report-store/neuroblastoma-market
Healthcare Consulting Service
DelveInsights multidimensional, purposeful, and credible pharma and medtech consulting services will aid in the acceleration of product services, including aspects such as congress intelligence, conference coverage, CI asset/indication tracking, brand presence and penetration assessment, drug therapy uptake, and diagnostic landscape assessment to overcome several market challenges.
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Contact Us:
Ankit Nigam
Assistant Manager Marketing
+91-9650213330
0 notes
Text
0 notes
Text
Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022
Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022
The global plasmapheresis market will grow at a CAGR of 8.3% during the forecast period to reach USD 1,285.3 million by 2022, according to this latest publication from Meticulous Research®. The global plasmapheresis market is driven by increasing demand for source plasma from biopharmaceutical companies, increasing the incidence of autoimmune diseases, and favorable reimbursement for therapeutic plasmapheresis procedure. However, the high cost of plasmapheresis devices & procedures and lack of awareness about apheresis collection among the population in emerging countries is expected to hamper the growth of plasmapheresis market during the forecast period.
Market Segmentation
Global plasmapheresis market is segmented by product type (instrument and disposables), by technology (membrane filtration and centrifugation), by applications (therapeutic plasmapheresis and source plasma collection), by end user (biopharmaceutical companies, hospitals & clinics, and others), and by geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Source plasma collection/donor plasmapheresis segment dominates the global plasmapheresis market and is also expected to increase significantly in the next 5-10 years. The large share of this segment is mainly attributed to increasing demand of source plasma from plasma fractionation industry and rising demand for plasma for transfusion in a patient with various diseases.
Geographic Overview
Geographically, the global plasmapheresis market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global plasmapheresis market in 2016, followed by Europe, and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher adoption of plasmapheresis for source plasma collection in the U.S. & Canada, increasing incidence of autoimmune disorders, well-established healthcare system, and favorable reimbursement in the U.S. for TPE procedures performed in hospitals. However, Asian countries are slated to register the fastest growth during the forecast period, owing to the rising healthcare spending, rising living standards, increasing awareness about plasmapheresis procedure, and growing plasma fractionation industry.
Key players
The global plasmapheresis market is oligopolies with top three players accounting for major share of the market in 2016. The major players providing plasmapheresis instrument and disposables in the global plasmapheresis market are B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Terumo Corporation (Japan), Kawasumi Laboratories Inc. (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Kaneka Corporation (Japan), Infomed SA (Switzerland), and Shanghai Dahua Medical Apparatus Co., Ltd. (China).
Scope of the Report:
Plasma Fractionation Market, by Product
Immunoglobulins
Intravenous Immunoglobulins (IVIg)
Subcutaneous Immunoglobulins (SCIg)
Intramuscular Immunoglobulins (IMIg)
Coagulation Factors
Albumin
Protease Inhibitors
Other Products
Note: Other plasma-derived products include fibrin, sealant, and plasma
Plasma Fractionation Market, by Application
Immunology
Hematology
Neurology
Critical Care
Hematology-oncology
Rheumatology & Orthopedics
Other Applications
Note: Other applications include the management of respiratory diseases and wound healing.
Plasma Fractionation Market, by End User
Hospitals & Clinics
Clinical Research Laboratories
Academic & Research Institutes
Plasma Fractionation Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific
China
Japan
India
Australia
Indonesia
Vietnam
Thailand
Malaysia
Rest of Asia-Pacific (RoAPAC)
Latin America
Brazil
Mexico
Columbia
Peru
Rest of Latin America (RoLATM)
Middle East & Africa
South Africa
Rest of Middle East & Africa
Download Sample Report -https://www.meticulousresearch.com/product/plasma-fractionation-market-5117?utm_source=PR&utm_medium=BLOG&utm_campaign=Product&utm_content=23-11-2022
0 notes
Text
Plasma Protein Therapeutics Market – Know the Latest Profit Sources of the Industry
Plasma Protein Therapeutics Market: Overview
According to Transparency Market Research’s latest report on the Plasma Protein Therapeutics Market for the historical period 2017–2018 and forecast period 2019–2027, Growing Investment in Innovation, Rising Demand for Immunoglobulin (IG), Rising Indications and Therapeutic use of Plasma Derived Protein Therapeutics are projected to drive the plasma protein therapeutics market
According to the report, the Plasma Protein Therapeutics Market was valued at US$ 22.41 Bn in 2018 and is projected to expand at a CAGR of 7.0% from 2019 to 2027
Growing Investment in Innovation: Key Drivers
Quality and advancements have been the success drivers of the plasma protein industry in order to increase the quality of life of patients and to guarantee donor safety. Plasma acquired via apheresis technology or complete blood donation processing can either be assembled or fractionated into plasma protein products that comprise one or more purified plasma protein or transfused directly to patients.
Get Sample Copy of the Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10424
The plasma protein industry has been investing in research and development of new plasma proteins therapies (e.g.: Ceruloplasmin, IgA, Plasmin) leading to innovative treatments for the benefits of patients. In March 2016, Grifols announced that it will invest US$ 360 Mn to expand production capabilities for plasma-derived therapies. The investment will increase the plasma fractionation capacity and purification of several proteins.
This has been also evident from advancements such as the product presentations (e.g. subcutaneous IG, IVIG 10% concentration, and IVIG liquid presentation), manufacturing process (e.g. improvement of yield), added virus elimination technologies (e.g. nanofiltration), and development of new plasma proteins (e.g. protein C and purified factor V)
Technological advancements in efficient and cost-effective procedures for fractionating proteins from plasma are anticipated to boost the plasma protein therapeutic market. According to the World Health Organization, global blood donation come from the high income countries, i.e., more than half of the 108 million, which is the home for 18% of the world’s population.
Rising incidence of over 200 life threatening diseases affecting immune or neurological system such as chronic inflammatory demyelinating polyneuropathy (CIPD), multifocal motor neuropathy (MMN), ideopathic thrombocytopenic purpura (ITP), and other infectious diseases including hepatitis A&B, rabies, tetanus, and varicella is driving the market.
Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=10424
Rising Demand for Immunoglobulins (IG)
The number of clinical indications for IG has been increasing. IG has become an important treatment option in a number of clinical indications beyond primary immunodeficiency, including autoimmune and acute inflammatory conditions. Also, off-label prescribing has crossed over into almost every medical specialty. Chronic use of off-label prescribing in some indications, particularly for the treatment of some neurological illnesses, in addition to immune deficiencies is increasing demand for IG.
Plasma-derived IG is used for a wide range of autoimmune and inflammatory diseases. Increased recognition and treatment of immune deficiencies in developing world have added to the global demand for IG. However, increased use of high dose therapy, particularly in autoimmune neurologic diseases is the major reason for the continued strong growth in demand for IG products.
Widespread off-label use of IG demonstrates use of large volume of plasma. Examples of most common off-label uses for IVIG in the U.S. are multifocal motor neuropathy (MMN), acute panautonomic polyneuropathy, hemolytic disease of the newborn, autoimmune mucocutaneous blistering diseases, and acute cardiomyopathy.
The clinical demand for these medicines has increased in the past few years and the trend is likely to continue due to constant improvement in diagnosis and improved life-expectancy
Read Report Overview: https://www.transparencymarketresearch.com/plasma-protein-therapeutics-market.html
Stringent Regulation and Reimbursement Issues Threat to Hamper Market
The plasma collection standards in emerging countries do not match those required by the fractionators. These regions follow strict rules and regulations regarding the quality of their operations, starting with the quality of the raw material. Specific fractionators are designed for plasma. For instance, the European health authorities require that the plasma pool for fractionation be tested for HIV, hepatitis A, B and C, and Parvovirus B. The blood collected by many centers is often unable to comply with these regulations, causing some recovered plasma to be unused.
Health budgets have been subjected to growing pressures. Funding through reimbursement pathways from private and public payers has come under inspection and it has drawn plasma protein therapies into the landscape of Health Technology Assessments (HTA), including the possible application of cost-utility analysis (CUA) in the distribution of reimbursement funds. Given the high cost of the therapies and the comparatively nascent nature of many of the indications, application of these tools of health economics can constraint the supply of products for patients in genuine need.
Regulatory and quality policies affect every step of the plasma protein therapy lifecycle, which includes donor safety, quality and compliance, biological license application process, therapy safety and efficacy, and pharmacovigilance. For example, licensing and inspecting of plasma collection centers and plasma protein therapy manufacturing facilities can be tedious and time consuming.
Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=10424
Plasma protein therapies used by Medicare beneficiaries predominately are reimbursed through Medicare Part B, which covers physician-administered therapies. In addition to being a complex technology, prices of raw materials and multiple safety measures contribute to the cost of these products. Hence, it is essential that reimbursement for plasma protein therapies is sufficient to maintain access.
Plasma Protein Therapeutics Market: Competitive Landscape
Baxter International
Biotests
CSL Behring
GRIFOLS, S.A
Kedrion
Octapharma USA, Inc.
Shire Plc.
China Biologics.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
0 notes
Text
Blood Collection Devices Market : Future, Growth and Trends In Market Research Industry
The COVID-19 outbreak is an unprecedented global public health challenge and is expected to have a significant impact on the blood collection devices market.
Both hospital and independent laboratories are generally reviewing each test to decide whether to recommend consultations with laboratory hematologists for tests with a higher risk profile or not offer tests that could not be performed safely. This affected the market negatively in the first few months of the pandemic, reducing the use of blood collection devices. However, increasing caution and the rising testing volumes, along with the need for regular health and body checkups will ensure market growth in a later phase.
Results now take an average of four to six days for the general population, much longer than the two to three days required before. This is because tests for hospital patients and symptomatic healthcare workers are prioritized and take one day on average, which has resulted in a delayed cycle. While it has affected market growth to some extent, the situation is expected to change for the better.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39733117
This scenario has ensured greater adherence to health checkups and the growing importance of markers to find disease conditions mainly via blood collection. Health checkups are gaining popularity both at a personal level as well as performed at a corporate level for employee well-being. This will be favorable for the market growth and a significant contributor to the blood collection devices market, as blood tests are a primary mode of diagnosing these diseases.
The cost of therapeutic apheresis is also very high, as it includes the additional cost of disposables—between USD 1,500 and USD 3,000 per patient. Owing to their high costs, the adoption of these automated blood collection products is very low as compared to manual blood collection products in countries such as China and India. This is limiting the overall growth of the blood collection devices market.
The cost of providing apheresis therapy is a matter of almost universal concern. Estimates of costs of individual apheresis treatments are very much available but vary widely. For instance, in the US, the cost of an apheresis procedure is approximately USD 2,500 per treatment. An investment of USD 19,000 to USD 32,000 for a blood cell separator is the initial cost for setting up the machine, and disposable sets produced by manufacturers will vary between USD 40 and USD 90 per treatment.
Storing and shipping whole blood samples poses significant challenges and costs. Once collected, whole blood must be used immediately or stored and maintained under strict temperature and environmental conditions for analysis or other applications. The characteristics of blood samples begin to change within hours of collection if not refrigerated or frozen.
On the basis of end user, the Blood Collection Devices Market is segmented into hospitals, ASCs, & nursing homes, blood banks, diagnostic & pathology laboratories, and other end users. In 2020, the hospitals, ASCs, & nursing homes segment accounted for the largest share of the market.
1 note
·
View note
Text
Leukapheresis Products Market Competitive Landscape, Growth Factors, Revenue Analysis Till 2027
Leukapheresis procedure in which white blood cells (WBCs) are separated from a sample of blood. Leukapheresis is majorly carried out for chronic lymphocytic leukemia. It is anticipated that the market held a market value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period.
Currently, many companies are operating in the global leukapheresis products market. The prominent players in the market are engaged in strategic collaborations, acquisitions, regional expansion, and new product launches to strengthen their market position. For instance, in February 2018, Terumo BCT entered into collaboration with Stafa Cellular Therapy. With this collaboration, Terumo BCT will act as a distributor for Stafa Cellular Therapy and will expand its access to StafaCT software to healthcare organizations.
The factors such as increasing number of blood donations, rising prevalence of leukemia, and demand for leukapheresis products in clinical research are anticipated to propel the growth of the market over the forecast period. According to the National Institutes of Health (NIH) estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the period from 2006-2015. It also stated that the number of new cases may reach 60,300 in the year 2018. Despite the drivers, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hamper the market growth over the assessment period.
Key Players:
Some of the prominent players in the global leukapheresis products market are Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, and StemExpress
Regional Analysis:
Geographically, the Americas is anticipated to dominate the global leukapheresis products market owing to the rising number of blood donations, and growing incidence and prevalence of leukemia. Europe is anticipated to hold the second largest position in the global leukapheresis products market. The market growth in this region is mainly due to the rising prevalence of leukemia and presence of well-developed healthcare sector in the region. Asia-Pacific region is expected to be fastest growing region due to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major pharma and biotech companies. The Middle East & Africa has the least share of the global leukapheresis products market owing the poor healthcare infrastructure especially in the Africa region.
Segmentation:
The global leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.
The market, by application, has been segmented into research applications and therapeutic applications.
On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
0 notes
Text
Leukapheresis Products Market to Witness a Healthy Growth by 2031
Leukapheresis Products Market Overview
Leukapheresis is the treatment of Leukaemia to reduce WBC count in the patient’s body. Globally there is a significant increase in the incidence and prevalence of leukaemia, in 2019, as per the Leukaemia and Lymphoma Society (LLS), more than 61,000 patients were diagnosed with leukaemia.
The leukapheresis products market is expected to grow at a good pace due to the prevalence of the disease at a good CAGR during the forecast period (2021-2031).
What is Driving Demand for Leukapheresis Products Market?
Major drivers of the Leukapheresis products market are an increased number of blood donations, increased initiatives by key players in the leukapheresis market’s field, and frequent advancement in medical technology and Research sciences. The Leukapheresis products market is expected to grow at an explosive CAGR during the forecast period of 2021-2031.
One of the best examples of demand drivers of sales of leukapheresis products is the production and excessive sales of “Leukopaks”, which are enriched with high concentrations of lymphocytes containing leukapheresis products.
What is the Repercussion of the Pandemic on the Growth of the Leukapheresis Products Market?
According to a detailed analysis, the pandemic should have a big positive impact on the leukapheresis market since a lot of clinical trials were done widely for COVID-19 vaccines. NIH is also conducting trials that have a requirement of leukapheresis for understanding the effects of SARS-CoV-2 on WBCs.
In the year 2021, it was observed that exponential growth was observed as per the factual statistics done by WHO, so there is a huge possibility that this market is going to face a big profit during the forecast period.
For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-13214
The US and Canada Leukapheresis Products Market Outlook
The largest share in the Leukapheresis product market is held by the North American region (the US and Canada), as a dominant percentage of market share is occupied by North American Leukapheresis market. An increase in neurological disorders and blood-related disorders like “Leukemia” which are already very incident and prevalent in this region makes these disorders the major drivers of the given leukapheresis market.
According to a press release, by 2027 Leukapheresis product market is to surpass the sales with the boom blast growth when compared to 2020. In 2020, the leukapheresis product market exhibited a beautifully high CAGR or would exhibit an even more rate of growth during the forecast period (2021-2031). Since the cost of Leukapheresis is very high it acts as a restraint on the Leukapheresis market in the end-user segment of hospitals and blood donation banks but the value of leukapheresis in the therapeutic and research sector is expected to gain pace.
Demand Outlook for Leukapheresis Products Europe market
The European region (majorly Germany, UK, Belgium, and Italy) occupy about a big chunk of the global leukapheresis market after the US and Canada combined which makes it the second-largest primary participant of the global market.
The European market of leukapheresis product is predicted to show a good percentage of CAGR as per the forecasted period of 2021-2028 since technological and medical advancements are not only helping the market growth but also there’s a growth of the markets which are linked to the leukapheresis products market due to which the revenue collection in the end-use industries like hospitals and apheresis units is pretty well.
Who are the Key Manufacturers and Suppliers of Leukapheresis Products?
Some of the leading manufacturers and suppliers of Leukapheresis products include
Haemonetics Corporation
Frost and Sullivan
Fresenius SE & Co.
KGaA
Asahi Kasei Medical Co. Ltd.
StemExpress, LLC
AllCells, LLC
Cerus Corporation
Charles River Laboratories
Hemacare Corporation
Terumo BCT, Inc
Fresenius medical care
Macopharma SA.
Fresenius Kabi.
In 2020, a plasmapheresis treatment was provided to a COVID-19 using highly advanced medical equipment which was installed in the GMC, Kerala for the treatment of apheresis. This upgrade shows how the future of the leukapheresis market lies in the Asia Pacific region with an incredible CAGR percentage.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13214
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Leukapheresis Products Market Report Highlights:
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.
Key Segments of Leukapheresis Products Market
By Product Type:
Leukapheresis Columns & Cell Separators
Leukapheresis Disposables
Apheresis Devices
Leukoreduction Filters
By Applications:
Therapeutic applications
Research applications
By Region:
North America
Latin America
Western Europe
Eastern Europe
Asia Pacific
Japan
Middle East and Africa
US & Canada
Brazil, Mexico, Others
EU5
Nordics
Benelux
Australia and New Zealand (ANZ)
Greater China
India
ASEAN
Rest of Asia Pacific
GCC Countries
the Other Middle East
North Africa
South Africa
Other Africa
Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-13214
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
0 notes
Text
Apheresis Equipment Market Focuses On Top Companies, Drivers And Opportunities
The global apheresis equipment market is anticipated to reach over USD 5,351.17 Million by 2026 according to a new research published by Polaris Market Research
An apheresis apparatus is a device which collects blood that is detached from a donor’s or patient’s body and splits up it into its several constituents such as red blood cells, platelets, plasma, and white blood cells. Depending on the purpose for apheresis, one of these constituents is collected and isolated by the equipment, while the others components are reverted to the body.
Polaris Market Research’s report on apheresis equipment market spans more than 90 pages and includes more than 70 tables and figures. Browse the detailed table of contents for, “By Procedure Type (Plasmapheresis, Plateletpheresis, Leukapheresis, Lymphopheresis, Erythrocytapheresis); By Application (Blood Donation, Therapeutic Purpose); By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Blood Donation Centers); By Regions (North America – U.S., Canada; Europe – Germany, UK, France, Italy, Russia; Asia-Pacific – China, India, Japan, Australia; Latin America – Brazil, Mexico; Middle East & Africa – UAE, Saudi Arabia, South Africa)]: Market size & Forecast, 2017 – 2026” on
Get Sample copy of report: https://www.polarismarketresearch.com/industry-analysis/global-apheresis-equipment-market/request-for-sample
Rising occurrence of blood-related ailments leading to the increase in demand for plasma and platelets is expected to serve the market as a high influence rendering driver. Moreover, the apheresis equipment market is driven by advancement in technology intended at delivering comparatively more rapid and effective results. Healthcare experts and researchers are now in the need for instruments that require minimum human involvement and institution of fully automatic apheresis equipment with improved displays is anticipated to augment the usage rates further bolstering the market growth.
The global apheresis equipment market is segmented on the basis of procedure type, application, end user, and geography. On the basis of procedure type, the global Apheresis Equipment Market is segmented into Plasmapheresis, Plateletpheresis, Leukapheresis, Lymphopheresis, and Erythrocytapheresis. In 2017, the Plasmapheresis is estimated to dominate the market growth. Increasing occurrence of blood-related diseases and rising demand for plasma-derived drugs are anticipated to serve as a primary growth driver of this segment. On the basis of application, the global apheresis equipment market is segmented into Blood Donation and Therapeutic Purpose. The therapeutic purpose is further categorized into Renal, Hematology, and Other Rare Diseases. On the basis of the end user, the global apheresis equipment market is segmented into hospitals, clinics, ambulatory surgical centers, and blood donation centers. On the basis of end users, the hospital segment is anticipated to dominate the market growth in 2017.
Some major key players in global apheresis equipment market include Haemonetics Corporation, Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., Terumo BCT, Inc., HemaCare Corporation, Therakos, Inc. and B. Braun Melsungen AG among others.
Request Discount: https://www.polarismarketresearch.com/industry-analysis/global-apheresis-equipment-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world
Contact us
Polaris Market Research
Phone: 1-646-568-9980
Email: [email protected]
Web: www.polarismarketresearch.com
0 notes
Text
Natural Killer Cells Therapeutics Market Analysis and Forecasts Research Report 2021-2030
Natural killer (NK) cells, also known as large granular lymphocytes (LGL), are defined as a type of cytotoxic lymphocyte which is critical to the innate immune system in the human body. NK cells belong to the innate lymphoid cells (ILC) which is a rapidly expanding family in the world of biological cells. They represent 5% to 20% of all circulating lymphocytes in humans. They are useful in the treatment of various types of cancers. Hence, many scientists are conducting research to explore new possible uses of NK cells regarding medical treatment. Increase in medical research in the field of natural killer cells therapeutics is profusely driving the growth of global natural killer cells therapeutics market. In recent years, scientists have started to re-engineer T cells to attack evasive tumors and creating the first Chimeric antigen receptor (CAR)-T treatments. Many researchers have also started to seriously explore how to do the same with natural killers. Experiments have been carried out by attaching CARs for CD19 to natural killer cells. With the cells being injected into patients with either non-Hodgkin lymphoma or chronic lymphocytic leukemia, so far majority cases have been turned out to be positive as the tumors of majority patients vanished.
Access the Full Report @ https://www.absolutemarketsinsights.com/reports/Natural-Killer-Cells-Therapeutics-Market-2021---2029-862
Investments towards enhancing effectiveness of natural killer cells therapeutics showcases positive growth opportunities for the global natural killer cells therapeutics market over the forecast period. CAR T is a new cell-based cancer immunotherapy. To provide a therapeutic anticancer effect, NK cells do not need any kind of antigen-specific priming. The efficacy of CAR modified peripheral blood natural killer cells being used for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia has been proven. Due to the spread of the China-originated coronavirus disease 2019 (COVID-19) which is also known as SARS-CoV-2 (SARS stands for Severe Acute Respiratory Syndrome), the immunological characteristics of COVID-19 are being researched. In some countries, NK cells are being experimented with the methods of lymphopenia to minimize the damage that coronavirus can cause to patients. A research to find a method using natural killer cells therapeutics for COVID treatment can be a big opportunity for the global natural killer cells therapeutics market.
Key Findings of the Report:
The global natural killer cells therapeutics market is anticipated to reach US$ 6317.20 Mn by 2029 growing at a CAGR of 17% during the forecast period (2021-2029).
The NK cell therapies category in the global natural killer cells therapeutics market held the larger market share in 2020. NK cells are capable of recognizing a wide range of ligands. Each of these can induce a cytolytic response. NK cells can also be easily isolated and expanded ex vivo. This allows for their use in adoptive or autologous cell therapies.
Cancer emerged as a dominant category under therapeutic indication in the global natural killer cells therapeutics market. The potent innate immune system effectors for cancer treatment can be harnessed from natural killer cells therapeutics. For example, in anticancer therapy, the checkpoint immunotherapy targets inhibitory receptors of T cells and reverses their functional blocking.
The peripheral blood segment held the largest share in the global natural killer cells therapeutics market in 2020. A medical technique called leukapheresis has made it possible to harvest cells directly from the peripheral blood of a donor. In this technique, immune cells are separated out from red blood cells. Peripheral blood mononuclear cells (PBMCs) are the most common source of NK cells. It is possible to collect PBMCs through apheresis or a specific gravity centrifugal method such as Ficoll separation.
Considering the end users segment, the hospitals & clinics segment occupied the largest market share in 2020 and is also anticipated to witness highest CAGR during the forecast period.
In 2020, North America was the biggest regional market in the global natural killer cells therapeutics market due to advanced medical research that was carried out in the medical institutions located in USA and Canada. Developed medical sector, presence of key market players, and technological advancement supporting the medical research, are some of the prominent factors contributing to the market growth in this region.
Some of the major players operating in the global natural killer cells therapeutics market are Acepodia Inc., Affimed GmbH, Artiva Biotherapeutics Inc., Bellicum Phamaceuticals Inc., Cytovia Therapeutics, Dragonfly Therapeutics, EMERCell, Fate Therapeutics, Fortress Biotech Inc., Glycostem, ImmunityBio Inc., Innate Pharma S.A., Kiadis Pharma, Nkarta Inc., NKGen Biotech, NKMAX Co. Ltd., and ONK Therapeutics Limited amongst others.
Global Natural Killer Cells Therapeutics Market:
By Type
NK Cell Therapies
Antibody Directed NK Cell Therapies
By Therapeutic Indication
Cancer
Viral Infections
Autoimmune Diseases
Neurodegenerative Diseases
Others
By Source
Peripheral Blood
Umbilical Cord Blood
Induced Pluripotent Natural killer cells therapeutics (iPSC)
Others
By End Users
Hospitals & Clinics
Research Institutes
Others
By Region:
North AmericaS.
Canada
Mexico
Rest of North America
EuropeFrance
The UK
Spain
Germany
Italy
Nordic CountriesDenmark
Finland
Iceland
Sweden
Norway
Benelux UnionBelgium
The Netherlands
Luxembourg
Rest of Europe
Asia PacificChina
Japan
India
New Zealand
Australia
South Korea
Southeast AsiaIndonesia
Thailand
Malaysia
Singapore
Rest of Southeast Asia
Rest of Asia Pacific
Middle East & AfricaSaudi Arabia
UAE
Egypt
Kuwait
South Africa
Rest of Middle East & Africa
Latin AmericaBrazil
Argentina
Rest of Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: [email protected]
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: https://www.absolutemarketsinsights.com
0 notes
Text
Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022
Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022
The global plasmapheresis market will grow at a CAGR of 8.3% during the forecast period to reach USD 1,285.3 million by 2022, according to this latest publication from Meticulous Research®. The global plasmapheresis market is driven by increasing demand for source plasma from biopharmaceutical companies, increasing the incidence of autoimmune diseases, and favorable reimbursement for therapeutic plasmapheresis procedure. However, the high cost of plasmapheresis devices & procedures and lack of awareness about apheresis collection among the population in emerging countries is expected to hamper the growth of plasmapheresis market during the forecast period.
Market Segmentation
Global plasmapheresis market is segmented by product type (instrument and disposables), by technology (membrane filtration and centrifugation), by applications (therapeutic plasmapheresis and source plasma collection), by end user (biopharmaceutical companies, hospitals & clinics, and others), and by geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Source plasma collection/donor plasmapheresis segment dominates the global plasmapheresis market and is also expected to increase significantly in the next 5-10 years. The large share of this segment is mainly attributed to increasing demand of source plasma from plasma fractionation industry and rising demand for plasma for transfusion in a patient with various diseases.
Geographic Overview
Geographically, the global plasmapheresis market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global plasmapheresis market in 2016, followed by Europe, and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher adoption of plasmapheresis for source plasma collection in the U.S. & Canada, increasing incidence of autoimmune disorders, well-established healthcare system, and favorable reimbursement in the U.S. for TPE procedures performed in hospitals. However, Asian countries are slated to register the fastest growth during the forecast period, owing to the rising healthcare spending, rising living standards, increasing awareness about plasmapheresis procedure, and growing plasma fractionation industry.
Key players
The global plasmapheresis market is oligopolies with top three players accounting for major share of the market in 2016. The major players providing plasmapheresis instrument and disposables in the global plasmapheresis market are B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Terumo Corporation (Japan), Kawasumi Laboratories Inc. (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Kaneka Corporation (Japan), Infomed SA (Switzerland), and Shanghai Dahua Medical Apparatus Co., Ltd. (China).
Scope of the Report:
Plasma Fractionation Market, by Product
Immunoglobulins
Intravenous Immunoglobulins (IVIg)
Subcutaneous Immunoglobulins (SCIg)
Intramuscular Immunoglobulins (IMIg)
Coagulation Factors
Albumin
Protease Inhibitors
Other Products
Note: Other plasma-derived products include fibrin, sealant, and plasma
Plasma Fractionation Market, by Application
Immunology
Hematology
Neurology
Critical Care
Hematology-oncology
Rheumatology & Orthopedics
Other Applications
Note: Other applications include the management of respiratory diseases and wound healing.
Plasma Fractionation Market, by End User
Hospitals & Clinics
Clinical Research Laboratories
Academic & Research Institutes
Plasma Fractionation Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific
China
Japan
India
Australia
Indonesia
Vietnam
Thailand
Malaysia
Rest of Asia-Pacific (RoAPAC)
Latin America
Brazil
Mexico
Columbia
Peru
Rest of Latin America (RoLATM)
Middle East & Africa
South Africa
Rest of Middle East & Africa
Download Sample Report -https://www.meticulousresearch.com/product/plasma-fractionation-market-5117?utm_source=PR&utm_medium=BLOG&utm_campaign=Product&utm_content=23-11-2022
0 notes
Text
Photopheresis Products Market is Set to Grow According to Latest Research Report by 2029-2027
Photopheresis Products Market:Overview
Transparency Market Research (TMR) has published a new report titled, Photopheresis Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global photopheresis products market was valued at US$ 262.4 Mn in 2018 and is projected to expand at a CAGR of above 5.3% from 2019 to 2027.
Overview
· Photopheresis products are mainly used to treat cutaneous T-cell lymphoma conditions. In the photopheresis treatment procedure white blood cells are collected from the blood and they are mixed with photosensitizer and treated with UV light. New therapeutic indications options are boosting the growth of this market.
· Furthermore, photopheresis therapy is majorly used in treating the patients who are not responding to steroids therapy in transplant rejection conditions. Photopheresis therapy is safer therapy when compared with steroids due to lack of side effects.
· North America dominated the global photopheresis therapy market in 2018 and the trend is anticipated to continue during the forecast period, As Governments provide reimbursement for various disease indications such as GVHD, CTL, and lung transplantations that are treated by ECP therapy.
Request A Sample:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14771
Corporate entities boosting the research activities on ECP therapy to Drive Photopheresis Products Market
· Corporates are actively encouraging research on photopheresis treatment by providing monetary support to researchers.
· In 2014, FreseinusKabi conducted an award contest on advanced research in therapeutic apheresis and cell therapy. The company has granted US$ 100,000 to the research team led by John Koreth, Dana Farber Cancer Institute, for his work on treating chronic GvHD condition by using photopheresis and low-dose interleukin-2 (IL-2).
Closed System Segment to Capture Largest Market Share
· Based on product, closed system devices has the highest revenue as compared to open systems and is expected to be dominate over the forecast period in 2019, as closed photopheresis system is the only FDA approved system to treat CTL conditions.
Graft versus host disease to dominate Market in Term of Therapeutic Application
· Based on therapeutic area, the market has been segmented into cutaneous T-cell lymphoma, graft versus host disease, transplant rejections and autoimmune diseases. Graft versus host disease is expected to dominate the market over the forecast period due to increase in allogeneic stem cell transplantations worldwide. In addition to that, increase in usage of photopheresis therapy in organ transplantations are boosting the growth of this market over the forecast period
Hospital to be Highly Lucrative Segment
· Based on end-user, the global photopheresis products market has been divided into hospitals and specialty clinics. The hospitals segment is anticipated to expand at the highest CAGR during the forecast period. Availability of multiple treatments options in hospitals enables patients to opt more for hospitals than specialty clinics.
Request Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14771
North America to Dominate Global Market
· In terms of region, the global photopheresis products market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global photopheresis products market in 2019, followed by Europe.
· The growth of the photopheresis products market in North America is attributed to the favorable reimbursement scenario and increasing prevalence of cutaneous T cell lymphoma and GvHD conditions. In 2012, Medicare extended reimbursement coverage for ECP therapy to treat bronchiolitis obliterans syndrome (BOS), a chronic lung allograft transplant dysfunction in the U.S.
Competitive Landscape
· Companies have developed advanced photopheresis medical devices to overcome the problems of conventional medical devices. Conventional photopheresis systems are more prone to cause infections, leakage problems, and prolonged treatment time. Hence, companies are using advanced medical devices to overcome these problems.
· Key players in the global market include Macopharma, Med Tech Solutions GmbH, Haemonetics Corporation, Fresenius Kabi AG, Terumo Corporation, and Mallinckrodt Pharmaceuticals among others among others.
Request for covid19 Impact Analysis:https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=14771
More Trending Reports by Transparency Market Research:
https://www.globenewswire.com/news-release/2022/03/01/2393938/0/en/Centrifuge-Market-to-Grow-at-CAGR-of-4-4-during-Forecast-Period-Observes-TMR-
Study.htmlhttps://www.globenewswire.com/news-release/2022/03/10/2401154/0/en/Platelet-rich-Plasma-Market-to-Grow-at-CAGR-of-11-2-During-Forecast-Period-Notes-TMR-Study.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
0 notes
Link
0 notes
Text
Apheresis Equipment Market Size, Share, Growth, Regional Outlook And Forecast
The global apheresis equipment market is anticipated to reach over USD 5,351.17 Million by 2026 according to a new research published by Polaris Market Research
An apheresis apparatus is a device which collects blood that is detached from a donor’s or patient’s body and splits up it into its several constituents such as red blood cells, platelets, plasma, and white blood cells. Depending on the purpose for apheresis, one of these constituents is collected and isolated by the equipment, while the others components are reverted to the body.
Polaris Market Research’s report on apheresis equipment market spans more than 90 pages and includes more than 70 tables and figures. Browse the detailed table of contents for, “By Procedure Type (Plasmapheresis, Plateletpheresis, Leukapheresis, Lymphopheresis, Erythrocytapheresis); By Application (Blood Donation, Therapeutic Purpose); By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Blood Donation Centers); By Regions (North America – U.S., Canada; Europe – Germany, UK, France, Italy, Russia; Asia-Pacific – China, India, Japan, Australia; Latin America – Brazil, Mexico; Middle East & Africa – UAE, Saudi Arabia, South Africa)]: Market size & Forecast, 2017 – 2026” on
Get Sample copy of report: https://www.polarismarketresearch.com/industry-analysis/global-apheresis-equipment-market/request-for-sample
Rising occurrence of blood-related ailments leading to the increase in demand for plasma and platelets is expected to serve the market as a high influence rendering driver. Moreover, the apheresis equipment market is driven by advancement in technology intended at delivering comparatively more rapid and effective results. Healthcare experts and researchers are now in the need for instruments that require minimum human involvement and institution of fully automatic apheresis equipment with improved displays is anticipated to augment the usage rates further bolstering the market growth.
The global apheresis equipment market is segmented on the basis of procedure type, application, end user, and geography. On the basis of procedure type, the global Apheresis Equipment Market is segmented into Plasmapheresis, Plateletpheresis, Leukapheresis, Lymphopheresis, and Erythrocytapheresis. In 2017, the Plasmapheresis is estimated to dominate the market growth. Increasing occurrence of blood-related diseases and rising demand for plasma-derived drugs are anticipated to serve as a primary growth driver of this segment. On the basis of application, the global apheresis equipment market is segmented into Blood Donation and Therapeutic Purpose. The therapeutic purpose is further categorized into Renal, Hematology, and Other Rare Diseases. On the basis of the end user, the global apheresis equipment market is segmented into hospitals, clinics, ambulatory surgical centers, and blood donation centers. On the basis of end users, the hospital segment is anticipated to dominate the market growth in 2017.
Some major key players in global apheresis equipment market include Haemonetics Corporation, Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., Terumo BCT, Inc., HemaCare Corporation, Therakos, Inc. and B. Braun Melsungen AG among others.
Request Discount: https://www.polarismarketresearch.com/industry-analysis/global-apheresis-equipment-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world
Contact us
Polaris Market Research
Phone: 1-646-568-9980
Email: [email protected]
Web: www.polarismarketresearch.com
0 notes
Last Seen Blogs
